FDA decision on Eisai. Biogen Alzheimer’s drug due in January
The U.S. Food and Drug Administration will expedite its review of Eisai Co Ltd's (4523.T) and Biogen Inc's (BIIB.O) experimental ...
The U.S. Food and Drug Administration will expedite its review of Eisai Co Ltd's (4523.T) and Biogen Inc's (BIIB.O) experimental ...